Home
/
Oragenics, Inc. (OGEN)
Oragenics, Inc. (OGEN) Technical Analysis
Updated: 2026-05-01 06:10 UTC · Last close: 0.59 (-0.97%) · Support: 0.50 · Resistance: 0.69
Oragenics, Inc. (OGEN) technical analysis page covering price structure, support and resistance, momentum conditions and a fundamentals snapshot from WOI Scanner.
⚠️ Risk Line
losing 0.50 would weaken the current structure.
Quick Read
From a roadmap perspective, the setup is boxed by support near 0.50 and resistance around 0.69.
🔺 Technical Setup
Triangle
desc / bias DOWN
🎯 Decision Map
From a roadmap perspective, the setup is boxed by support near 0.50 and resistance around 0.69. A move through resistance would be needed to materially improve the chart, while a break of support would keep the pressure side dominant.
📊 Technical Summary
Oragenics, Inc. (OGEN) closed at 0.59 (-0.97%). Price remains below both the 50-day and 200-day moving averages, which keeps the broader technical backdrop under pressure until stronger recovery signals appear. 20-day momentum is notably strong at +8.04%, with price is trading in the lower part of its roughly 52-week range (0.50–6.00), while ATR14 volatility is elevated at roughly 9.26% of price. RSI(14) is 40.8, leaving momentum in a fairly neutral range. RSI has been drifting lower recently, suggesting that upside momentum may be cooling slightly. MACD remains below its signal line, which shows that momentum confirmation is still limited. The MACD histogram is negative and weakening further, which reflects continued downside pressure. The nearest decision zone is framed by support at 0.50 and resistance at 0.69. A move through resistance would improve the short-term technical tone, while a loss of support would weaken the current structure. Latest fundamentals snapshot: Revenue: 7,466 · Net income: -3.07M · EPS (basic): -1.96. The interactive view adds overlays, pattern context and broader chart structure for deeper review.
💼 Fundamentals Snapshot
Source: sec
Note: This is an algorithmic technical snapshot (not financial advice).